FR05C0030I2 - Derives d'azahexane heterocycliques a activite antivirale - Google Patents

Derives d'azahexane heterocycliques a activite antivirale

Info

Publication number
FR05C0030I2
FR05C0030I2 FR05C0030C FR05C0030C FR05C0030I2 FR 05C0030 I2 FR05C0030 I2 FR 05C0030I2 FR 05C0030 C FR05C0030 C FR 05C0030C FR 05C0030 C FR05C0030 C FR 05C0030C FR 05C0030 I2 FR05C0030 I2 FR 05C0030I2
Authority
FR
France
Prior art keywords
antiviral activity
heterocyclic
azahexane derivatives
heterocyclic azahexane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR05C0030C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27171723&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR05C0030(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of FR05C0030I1 publication Critical patent/FR05C0030I1/fr
Application granted granted Critical
Publication of FR05C0030I2 publication Critical patent/FR05C0030I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02—Compounds containing any of the groups, e.g. carbazates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02—Compounds containing any of the groups, e.g. carbazates
    • C07C281/04—Compounds containing any of the groups, e.g. carbazates the other nitrogen atom being further doubly-bound to a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR05C0030C 1996-04-22 2005-07-05 Derives d'azahexane heterocycliques a activite antivirale Active FR05C0030I2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH101896 1996-04-22
CH2997 1997-01-08
CH22397 1997-01-31
PCT/EP1997/001860 WO1997040029A1 (fr) 1996-04-22 1997-04-14 Derives d'azahexane heterocycliques a activite antivirale

Publications (2)

Publication Number Publication Date
FR05C0030I1 FR05C0030I1 (fr) 2005-08-12
FR05C0030I2 true FR05C0030I2 (fr) 2007-04-27

Family

ID=27171723

Family Applications (1)

Application Number Title Priority Date Filing Date
FR05C0030C Active FR05C0030I2 (fr) 1996-04-22 2005-07-05 Derives d'azahexane heterocycliques a activite antivirale

Country Status (28)

Country Link
EP (1) EP0900210B1 (fr)
JP (1) JP3174347B2 (fr)
CN (3) CN1310905C (fr)
AR (1) AR006720A1 (fr)
AT (1) ATE288903T1 (fr)
AU (1) AU706183B2 (fr)
BR (1) BR9701877A (fr)
CA (3) CA2510945C (fr)
CY (1) CY2596B2 (fr)
CZ (1) CZ296135B6 (fr)
DE (2) DE122005000003I1 (fr)
DK (1) DK0900210T3 (fr)
EA (1) EA001794B1 (fr)
ES (1) ES2238720T3 (fr)
FR (1) FR05C0030I2 (fr)
HK (2) HK1018788A1 (fr)
HU (1) HU224125B1 (fr)
IL (1) IL126381A (fr)
LU (1) LU91189I2 (fr)
MY (1) MY114457A (fr)
NL (1) NL300203I2 (fr)
NO (2) NO313330B1 (fr)
NZ (3) NZ509045A (fr)
PT (1) PT900210E (fr)
SI (1) SI0900210T1 (fr)
SK (1) SK285048B6 (fr)
TW (1) TW409125B (fr)
WO (1) WO1997040029A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087383A (en) * 1998-01-20 2000-07-11 Bristol-Myers Squibb Company Bisulfate salt of HIV protease inhibitor
US6251906B1 (en) 1998-05-15 2001-06-26 Abbott Laboratories Retroviral protease inhibiting compounds
JP2002515501A (ja) * 1998-05-15 2002-05-28 アボット・ラボラトリーズ レトロウイルスプロテアーゼの阻害化合物
US6096894A (en) * 1998-07-29 2000-08-01 Sumika Fine Chemicals Co., Ltd. Production method of 2-(p-alkylphenyl)pyridine compound
ATE239707T1 (de) * 1998-08-07 2003-05-15 Sumika Fine Chemicals Co Ltd 2-phenylpyridine-derivate und verfahren zu deren herstellung
US6207715B1 (en) 1998-12-09 2001-03-27 American Home Products Corporation Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a substituted phenylene-diamine group
US6335350B1 (en) 1998-12-09 2002-01-01 American Home Products Corporation Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
US6197803B1 (en) 1998-12-09 2001-03-06 American Home Products Corporation Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
US6255349B1 (en) 1998-12-09 2001-07-03 American Home Products Corporation Alph-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
JP4222671B2 (ja) 1999-02-15 2009-02-12 住友化学株式会社 ヒドラジン誘導体の製造方法
IT1313664B1 (it) 1999-10-12 2002-09-09 Norpharma S P A Processo per la preparazione di un composto aril-piridinico.
JP4278316B2 (ja) * 2000-07-14 2009-06-10 住友化学株式会社 ヒドラジン誘導体の製造方法
US6365745B1 (en) 2000-07-14 2002-04-02 Sumika Fine Chemicals Co., Ltd. Method for producing hydrazine derivative
WO2004037790A1 (fr) 2002-10-02 2004-05-06 Euticals Prime European Therapeuticals Spa Procede pour la preparation de composes d'aryl-piridyle
ATE424198T1 (de) * 2002-12-06 2009-03-15 Vertex Pharma Zusammensetzungen die eine kombination von diphenylharnstoff impdh-hemmern und apoptose- induzierenden antikrebsmitteln enthalten
ITMI20032338A1 (it) * 2003-11-28 2005-05-29 Dinamite Dipharma S P A In Forma A Bbreviata Diph Composti feniltetrazolici.
CN1980666B (zh) * 2004-05-04 2011-03-30 布里斯托尔-迈尔斯斯奎布公司 制备阿扎那韦硫酸氢盐的方法和新的形式
ATE429417T1 (de) 2005-02-10 2009-05-15 Medivir Ab Hiv-protease-inhibitoren
EP2069303B1 (fr) * 2006-07-21 2016-03-30 Gilead Sciences, Inc. Inhibiteurs de protease antiviraux
AU2008267048C1 (en) 2007-06-12 2013-01-17 Concert Pharmaceuticals, Inc. Azapeptide derivatives
WO2009130534A1 (fr) * 2008-04-24 2009-10-29 Oxyrane (Pty) Ltd. Procédé de synthèse d'atazanavir
EP2272830A1 (fr) * 2009-06-18 2011-01-12 Esteve Química, S.A. Procédé de préparation d'un dérivé d'azahexane hétérocyclique antiviral
EP2272831A1 (fr) 2009-06-26 2011-01-12 Prime European Therapeuticals S.p.A. Procédé pour la préparation de composés d'arylpyridinyl
WO2011037467A1 (fr) 2009-09-28 2011-03-31 Stichting Katholieke Universiteit Atazanavir pour le traitement de maladies inflammatoires
WO2011080562A1 (fr) 2009-12-29 2011-07-07 Hetero Research Foundation Nouveau aza-peptides contenant du cyclobutyl 2,2-disubstitué et/ou des dérivés alcoxy benzyle substitués comme agents antiviraux
US20130005780A1 (en) * 2010-03-01 2013-01-03 Lupin Limited Controlled release pharmaceutical compositions of tapentadol
CA2849546A1 (fr) 2010-09-28 2012-04-05 Ratiopharm Gmbh Traitement par voie seche de l'atazanavir
WO2013014633A1 (fr) * 2011-07-27 2013-01-31 Ranbaxy Laboratories Limited Procédé de préparation d'atazanavir ou de son sel bisulfate
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
CN104250224A (zh) * 2013-06-28 2014-12-31 上海威智医药科技有限公司 阿扎那韦富马酸盐及其制备和应用
CN104163787A (zh) * 2014-08-08 2014-11-26 山东威智医药工业有限公司 阿扎那韦及其硫酸盐的制备方法
CN107459496B (zh) * 2016-06-03 2022-07-19 华东理工大学 噻唑类衍生物在治疗病毒感染中的应用
JOP20180009A1 (ar) 2017-02-06 2019-01-30 Gilead Sciences Inc مركبات مثبط فيروس hiv
CN107245052A (zh) * 2017-06-21 2017-10-13 连云港杰瑞药业有限公司 一种阿扎那韦制备方法
TWI829205B (zh) * 2018-07-30 2024-01-11 美商基利科學股份有限公司 抗hiv化合物
CN109251165B (zh) * 2018-10-02 2022-09-23 国药集团川抗制药有限公司 阿扎那韦达二4-氨基苯磺酸盐及其制备方法
CN109574916A (zh) * 2018-12-29 2019-04-05 常州吉恩药业有限公司 阿扎那韦中间体2-[4-(2-吡啶基)苄基]-肼羧酸叔丁酯的工业化生产方法
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN113603634B (zh) * 2021-08-06 2023-03-21 江苏八巨药业有限公司 一种阿扎那韦中间体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913840A1 (en) * 1990-11-20 1992-05-20 Abbott Lab Retroviral protease inhibiting compounds
DK0521827T3 (da) * 1991-07-03 1996-11-11 Ciba Geigy Ag Farmakologisk virksomme hydrazinderivater og fremgangsmåde til deres fremstilling
DK0604368T3 (fr) * 1992-12-23 1997-02-24 Ciba Geigy Ag
DK0727419T3 (da) * 1992-12-29 2002-06-10 Abbott Lab Mellemprodukter til fremstilling af forbindelser, som inhiberer retroviral protease
US5461067A (en) * 1993-02-25 1995-10-24 Abbott Laboratories Retroviral protease inhibiting compounds

Also Published As

Publication number Publication date
JP3174347B2 (ja) 2001-06-11
DE122005000003I1 (de) 2005-05-25
CZ337398A3 (cs) 1999-01-13
FR05C0030I1 (fr) 2005-08-12
EA001794B1 (ru) 2001-08-27
CZ296135B6 (cs) 2006-01-11
AR006720A1 (es) 1999-09-08
CN1616453A (zh) 2005-05-18
HK1018788A1 (en) 2000-01-07
HK1075043A1 (en) 2005-12-02
CA2250840C (fr) 2006-07-04
CN1082508C (zh) 2002-04-10
HUP9901612A2 (hu) 1999-08-30
LU91189I2 (fr) 2005-10-03
NL300203I2 (nl) 2005-11-01
JPH11511177A (ja) 1999-09-28
DE69732483D1 (de) 2005-03-17
NO984900L (no) 1998-12-21
CA2568104C (fr) 2009-08-04
EP0900210A1 (fr) 1999-03-10
CY2596B2 (en) 2010-03-03
MY114457A (en) 2002-10-31
IL126381A (en) 2001-08-26
NO2005010I1 (no) 2005-05-02
NZ332118A (en) 2001-02-23
LU91189I9 (fr) 2018-12-27
CN1319587A (zh) 2001-10-31
AU2385997A (en) 1997-11-12
CN1216539A (zh) 1999-05-12
HUP9901612A3 (en) 2000-06-28
ES2238720T3 (es) 2005-09-01
SI0900210T1 (fr) 2005-08-31
NZ509045A (en) 2002-09-27
WO1997040029A1 (fr) 1997-10-30
NO313330B1 (no) 2002-09-16
ATE288903T1 (de) 2005-02-15
CA2510945A1 (fr) 1997-10-30
IL126381A0 (en) 1999-05-09
NL300203I1 (nl) 2005-10-03
DK0900210T3 (da) 2005-05-02
CA2510945C (fr) 2007-01-16
DE69732483T2 (de) 2005-07-28
CN1310905C (zh) 2007-04-18
BR9701877A (pt) 1998-09-29
NO984900D0 (no) 1998-10-21
TW409125B (en) 2000-10-21
SK285048B6 (sk) 2006-05-04
SK145298A3 (en) 1999-06-11
CN1193010C (zh) 2005-03-16
CA2568104A1 (fr) 1997-10-30
EP0900210B1 (fr) 2005-02-09
HU224125B1 (hu) 2005-05-30
CA2250840A1 (fr) 1997-10-30
PT900210E (pt) 2005-06-30
NZ509046A (en) 2002-05-31
EA199800899A1 (ru) 1999-10-28
AU706183B2 (en) 1999-06-10

Similar Documents

Publication Publication Date Title
FR05C0030I2 (fr) Derives d'azahexane heterocycliques a activite antivirale
FR11C0023I2 (fr) Derives de benzimidazole a activite antihistaminique
NO996106D0 (no) 4" - substituert - 9 -deokso-9A-AZA-9A-Homoerytromycin A- derivater
FI963539A (fi) (4,4-difluoribut-3-enyylitio)-substituoituja heterosyklisiä tai karbosyklisiä rengasyhdisteitä, joilla on tuhoeläinmyrkkyvaikutusta
NO994791D0 (no) Nikotinamid-derivater
TR199501209A2 (tr) Urea türevleri
DK0966477T3 (da) 3'-N-oxid, 3'-N-dimethylamin, 9-oxim-erythromycin A-derivater
ITMI912182A0 (it) Composti eterociclici ad attivita' a ii antagonista
FI954255A0 (fi) 2,9-diamino- ja 2-amino-8-karbaomyyli-4-hydroksi-alkaanihappoamidijohdannaiset
DE69820102D1 (de) Substituierte chromanderivate
FR2763953B1 (fr) Derives de 5'-desoxy-cytidine
ITMI921951A0 (it) Derivati imidazolici ad attivita' a ii antagonista
DE69820103D1 (de) Substituierte chromanderivate
FI955164A0 (fi) Heterosykliset johdannaiset
FI970110A0 (fi) Helico-bakteerin vastaisia heterosyklisiä atsolonijohdannaisia
DE69208351T2 (de) Halovinylderivate
PL327686A1 (en) Derivatives of @-amino 5,6-dichlorobenzimidazole exhibiting antiviral activity
FI950486A (fi) Amidijohdannaiset
BR9711110A (pt) Derivados de quinolina 4-substituidos tendo a atividade fungicida
NO961404D0 (no) 4-indolylpiperazinyl-derivater
MA23455A1 (fr) Derives de 2-imidazoline-5-ones fongicides
ITMI930819A0 (it) Derivati eterobiciclici ad attivita' fungicida
MA26481A1 (fr) Derives d'arylsecocholadiene
MA23579A1 (fr) Derives de 5-imino 2- imidazolines fongicides
FR2511370B1 (fr) Derives de 1,4-dihydropyridine a activite vasodilatatrice et d'hypotension